Literature DB >> 29333702

MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinoma.

Sima Ardalan Khales1, Ehsan Ebrahimi2, Eisa Jahanzad3, Sahar Ardalan Khales4, Mohammad Mahdi Forghanifard2.   

Abstract

AIMS: Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with considerable morbidity and mortality. Invasion and metastasis of HNSCC is a complex process involving multiple molecules and signaling pathways. Twist Family BHLH Transcription Factor 1 (TWIST1) and Mastermind-like 1 (MAML1) are essential in induction of epithelial-mesenchymal transition through direct regulation of implicated molecules in cellular adhesion, migration and invasion. Our aim in this study was to assess the clinical significance of MAML1 and TWIST1 expression in HNSCC, and elucidate the probable correlation between these genes to exhibit their possible associations with progression and metastasis of the disease.
METHODS: The gene expression profile of MAML1 and TWIST1 was assessed in fresh tumoral compared to distant tumor-free tissues of 55 HNSCC patients using quantitative real-time Polymerase chain reaction (PCR).
RESULTS: Significant overexpression of MAML1 and TWIST1 mRNA was observed in 49.1% and 38.2% (P ˂ 0.05) of tumor specimens, respectively. Overexpression of MAML1 was associated with vascular invasion (P = 0.048). Concomitant overexpression of MAML1 and TWIST1 was significantly correlated to each other (P = 0.004). Co-overexpression of the genes was significantly correlated to the various clinicopathological indices of poor prognosis including depth of tumor invasion (P < 0.01), lymphatic invasion and grade of tumor cell differentiation (P < 0.05).
CONCLUSIONS: Significant correlation between MAML1 and TWIST1 in HNSCC was revealed. This study was the first report elucidating MAML1 clinical relevance in HNSCC. These new findings suggest an oncogenic role for concomitant expression of MAML1 and TWIST1 genes in HNSCC invasion and metastasis.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  MAML1; TWIST1; concomitant overexpression; head and neck squamous cell carcinoma; quantitative real-time PCR

Mesh:

Substances:

Year:  2018        PMID: 29333702     DOI: 10.1111/ajco.12843

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  4 in total

1.  MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.

Authors:  Mohammad Mahdi Forghanifard; Shirin Azaraz; Sima Ardalan Khales; Dorsa Morshedi Rad; Mohammad Reza Abbaszadegan
Journal:  Mol Biol Rep       Date:  2020-03-16       Impact factor: 2.316

2.  Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.

Authors:  Reihaneh Alsadat Mahmoudian; Maryam Lotfi Gharaie; Mohammad Reza Abbaszadegan; Ali Alasti; Mohammad Mahdi Forghanifard; Atena Mansouri; Mehran Gholamin
Journal:  Mol Cell Biochem       Date:  2021-02-19       Impact factor: 3.396

3.  Screening and clinical significance of tumor markers in head and neck squamous cell carcinoma through bioinformatics analysis.

Authors:  Lei Zhao; Weiwei Chi; Huan Cao; Weina Cui; Wenxia Meng; Wei Guo; Baoshan Wang
Journal:  Mol Med Rep       Date:  2018-11-09       Impact factor: 2.952

4.  RBM24 Mediates Lymph Node Metastasis and Epithelial-Mesenchymal Transition in Human Hypopharyngeal Squamous Cell Carcinoma by Regulating Twist1.

Authors:  Yuhong Liu; Min Pan; Tao Lu; Yanshi Li; Dan Yu; Zhihai Wang; Guohua Hu
Journal:  J Oncol       Date:  2022-09-29       Impact factor: 4.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.